Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Harvard Business School
Healthtrust
Chinese Patent Office
Boehringer Ingelheim

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 9,987,271

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,987,271
Title:Method of treating nasopharyngeal carcinoma using perillyl alcohol derivative
Abstract: A method of treating nasopharyngeal carcinoma in a mammal includes delivering to the mammal a therapeutically effective amount of a perillyl alcohol (POH) carbamate which is a perillyl alcohol conjugated with temozolomide (TMZ).
Inventor(s): Chen; Thomas (La Canada, CA)
Assignee: NeOnc Technologies, Inc. (Los Angeles, CA)
Application Number:15/429,556
Patent Claims:see list of patent claims

Details for Patent 9,987,271

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up NeOnc Technologies, Inc. (Los Angeles, CA) 2034-10-27 RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up NeOnc Technologies, Inc. (Los Angeles, CA) 2034-10-27 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up NeOnc Technologies, Inc. (Los Angeles, CA) 2034-10-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,987,271

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Johnson and Johnson
US Army
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.